Published in J Spinal Cord Med on June 24, 2014
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem (1972) 95.79
Abdominal obesity and metabolic syndrome. Nature (2006) 14.20
Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial. Circulation (2006) 4.25
Atherogenesis: a postprandial phenomenon. Circulation (1979) 3.74
Increased small low-density lipoprotein particle number: a prominent feature of the metabolic syndrome in the Framingham Heart Study. Circulation (2005) 2.21
Postprandial lipoprotein metabolism and atherosclerosis. J Intern Med (1999) 1.74
Carbohydrate and lipid metabolism in chronic spinal cord injury. J Spinal Cord Med (2001) 1.74
Obesity after spinal cord injury. Phys Med Rehabil Clin N Am (2007) 1.53
Methods of estimation of visceral fat: advantages of ultrasonography. Obes Res (2003) 1.46
Coronary heart disease in individuals with spinal cord injury: assessment of risk factors. Spinal Cord (2008) 1.40
The effect of residual neurological deficit on oral glucose tolerance in persons with chronic spinal cord injury. Spinal Cord (1999) 1.32
Atherogenic nature of triglycerides, postprandial lipidemia, and triglyceride-rich remnant lipoproteins. Clin Chem (1995) 1.24
A technique for the measurement of visceral fat by ultrasonography: comparison of measurements by ultrasonography and computed tomography. Intern Med (2005) 1.12
Central adiposity associations to carbohydrate and lipid metabolism in individuals with complete motor spinal cord injury. Metabolism (2010) 1.07
iDXA, Prodigy, and DPXL dual-energy X-ray absorptiometry whole-body scans: a cross-calibration study. J Clin Densitom (2008) 1.05
Risk factors for atherogenesis and cardiovascular autonomic function in persons with spinal cord injury. Spinal Cord (1999) 1.02
Postprandial lipemia in men with metabolic syndrome, hypertensives and healthy subjects. Lipids Health Dis (2005) 0.95
Measurement of coronary artery calcification by electron beam computerized tomography in persons with chronic spinal cord injury: evidence for increased atherosclerotic burden. Spinal Cord (2007) 0.95
Assessment of measures for abdominal adiposity in persons with spinal cord injury. Ultrasound Med Biol (2011) 0.92
Influence of motor complete spinal cord injury on visceral and subcutaneous adipose tissue measured by multi-axial magnetic resonance imaging. J Spinal Cord Med (2011) 0.90
Remnant-like lipoprotein particle cholesterol concentration and progression of coronary and vein-graft atherosclerosis in response to gemfibrozil treatment. Atherosclerosis (2001) 0.89
Fasting serum apolipoprotein B-48 can be a marker of postprandial hyperlipidemia. J Atheroscler Thromb (2011) 0.87
Significance of measuring serum concentrations of remnant lipoproteins and apolipoprotein B-48 in fasting period. J Atheroscler Thromb (2009) 0.87
Ethnicity effect on the serum lipid profile in persons with spinal cord injury. Arch Phys Med Rehabil (1998) 0.86
The influence of visceral fat on the postprandial lipemic response in men with paraplegia. J Am Coll Nutr (2010) 0.85
Evidence for an exaggerated postprandial lipemia in chronic paraplegia. J Spinal Cord Med (2005) 0.82
Factors influencing body composition in persons with spinal cord injury: a cross-sectional study. J Appl Physiol (1985) (2003) 2.23
Smoking and obstructive lung dysfunction in persons with chronic spinal cord injury. J Spinal Cord Med (2003) 1.63
Spinal cord injury medicine. 2. Acute care management of traumatic and nontraumatic injury. Arch Phys Med Rehabil (2007) 1.63
Acupuncture for chronic shoulder pain in persons with spinal cord injury: a small-scale clinical trial. Arch Phys Med Rehabil (2007) 1.46
Vertical ground reaction force-based analysis of powered exoskeleton-assisted walking in persons with motor-complete paraplegia. J Spinal Cord Med (2013) 1.44
Pulmonary function and spinal cord injury. Respir Physiol Neurobiol (2009) 1.27
Bone and muscle loss after spinal cord injury: organ interactions. Ann N Y Acad Sci (2010) 1.22
Spinal cord injury medicine. 6. Economic and societal issues in spinal cord injury. Arch Phys Med Rehabil (2007) 1.10
Shoulder pain in chronic spinal cord injury, Part I: Epidemiology, etiology, and pathomechanics. J Spinal Cord Med (2004) 1.04
Dependence of dexamethasone-induced Akt/FOXO1 signaling, upregulation of MAFbx, and protein catabolism upon the glucocorticoid receptor. Biochem Biophys Res Commun (2008) 1.01
Testosterone protects against dexamethasone-induced muscle atrophy, protein degradation and MAFbx upregulation. J Steroid Biochem Mol Biol (2008) 1.01
Spinal cord injury medicine. 1. Epidemiology and classification. Arch Phys Med Rehabil (2007) 1.00
Decreased colonic motility in persons with chronic spinal cord injury. Am J Gastroenterol (2003) 1.00
Neuromotor and musculoskeletal responses to locomotor training for an individual with chronic motor complete AIS-B spinal cord injury. J Spinal Cord Med (2008) 0.99
Identification of androgen response elements in the insulin-like growth factor I upstream promoter. Endocrinology (2007) 0.96
Comparison of 24-hour cardiovascular and autonomic function in paraplegia, tetraplegia, and control groups: implications for cardiovascular risk. J Spinal Cord Med (2011) 0.96
REDD1 is a major target of testosterone action in preventing dexamethasone-induced muscle loss. Endocrinology (2009) 0.96
Evolving concepts in neurogenic osteoporosis. Curr Osteoporos Rep (2010) 0.95
Normalization of supine blood pressure after nitric oxide synthase inhibition in persons with tetraplegia. J Spinal Cord Med (2007) 0.95
Spinal cord injury medicine. 5. Long-term medical issues and health maintenance. Arch Phys Med Rehabil (2007) 0.93
Assessment of airway caliber and bronchodilator responsiveness in subjects with spinal cord injury. Chest (2005) 0.93
Spinal cord injury medicine. 4. Optimal participation in life after spinal cord injury: physical, psychosocial, and economic reintegration into the environment. Arch Phys Med Rehabil (2002) 0.93
Infusion of neostigmine-glycopyrrolate for bowel evacuation in persons with spinal cord injury. Am J Gastroenterol (2005) 0.93
Protection against dexamethasone-induced muscle atrophy is related to modulation by testosterone of FOXO1 and PGC-1α. Biochem Biophys Res Commun (2010) 0.92
Assessment of measures for abdominal adiposity in persons with spinal cord injury. Ultrasound Med Biol (2011) 0.92
Effects of midodrine hydrochloride on blood pressure and cerebral blood flow during orthostasis in persons with chronic tetraplegia. Arch Phys Med Rehabil (2010) 0.92
Age-related prevalence of low testosterone in men with spinal cord injury. J Spinal Cord Med (2013) 0.92
Blunted heart rate response to vagal withdrawal in persons with tetraplegia. Clin Auton Res (2006) 0.91
Differential skeletal muscle gene expression after upper or lower motor neuron transection. Pflugers Arch (2009) 0.91
Testosterone-induced hypertrophy of L6 myoblasts is dependent upon Erk and mTOR. Biochem Biophys Res Commun (2010) 0.91
Relationship of respiratory symptoms with smoking status and pulmonary function in chronic spinal cord injury. J Spinal Cord Med (2002) 0.90
Expression of the muscle atrophy factor muscle atrophy F-box is suppressed by testosterone. Endocrinology (2008) 0.89
Cognitive performance in hypotensive persons with spinal cord injury. Clin Auton Res (2009) 0.89
A center's experience: pulmonary function in spinal cord injury. Lung (2014) 0.89
Intramuscular neostigmine and glycopyrrolate safely accelerated bowel evacuation in patients with spinal cord injury and defecatory disorders. Dig Dis Sci (2008) 0.88
Arterial stiffness in persons with paraplegia. J Spinal Cord Med (2004) 0.87
Cardiac autonomic responses to progressive head-up tilt in individuals with paraplegia. Clin Auton Res (2003) 0.87
Spinal cord injury medicine. 2. Medical complications after spinal cord injury: Identification and management. Arch Phys Med Rehabil (2002) 0.87
Transient suppression of heart rate complexity in concussed athletes. Auton Neurosci (2009) 0.86
Direct and reflexive effects of nitric oxide synthase inhibition on blood pressure. Am J Physiol Heart Circ Physiol (2007) 0.86
Systemic and cerebral hemodynamics during cognitive testing. Clin Auton Res (2011) 0.86
Zoledronic acid administration failed to prevent bone loss at the knee in persons with acute spinal cord injury: an observational cohort study. J Bone Miner Metab (2014) 0.86
Oxandrolone blocks glucocorticoid signaling in an androgen receptor-dependent manner. Steroids (2004) 0.85
Differential alterations in gene expression profiles contribute to time-dependent effects of nandrolone to prevent denervation atrophy. BMC Genomics (2010) 0.85
Effect of low-dose baclofen administration on plasma insulin-like growth factor-I in persons with spinal cord injury. J Clin Pharmacol (2006) 0.85
The influence of visceral fat on the postprandial lipemic response in men with paraplegia. J Am Coll Nutr (2010) 0.85
Decentralized cardiovascular autonomic control and cognitive deficits in persons with spinal cord injury. J Spinal Cord Med (2013) 0.85
Transmission of low-intensity vibration through the axial skeleton of persons with spinal cord injury as a potential intervention for preservation of bone quantity and quality. J Spinal Cord Med (2011) 0.84
Structure and function of the upstream promotor of the human Mafbx gene: the proximal upstream promotor modulates tissue-specificity. J Cell Biochem (2005) 0.84
Spinal cord injury medicine. 5. Preserving wellness and independence of the aging patient with spinal cord injury: a primary care approach for the rehabilitation medicine specialist. Arch Phys Med Rehabil (2002) 0.84
The central nervous system (CNS)-independent anti-bone-resorptive activity of muscle contraction and the underlying molecular and cellular signatures. J Biol Chem (2013) 0.84
Heart rate and oxygen demand of powered exoskeleton-assisted walking in persons with paraplegia. J Rehabil Res Dev (2015) 0.84
Nandrolone normalizes determinants of muscle mass and fiber type after spinal cord injury. J Neurotrauma (2012) 0.83
Nandrolone slows hindlimb bone loss in a rat model of bone loss due to denervation. Ann N Y Acad Sci (2010) 0.82
Safety, tolerance, and efficacy of extended-release niacin monotherapy for treating dyslipidemia risks in persons with chronic tetraplegia: a randomized multicenter controlled trial. Arch Phys Med Rehabil (2011) 0.82
Autonomic recovery from peak arm exercise in fit and unfit individuals with paraplegia. Med Sci Sports Exerc (2006) 0.82
Airflow obstruction and reversibility in spinal cord injury: evidence for functional sympathetic innervation. Arch Phys Med Rehabil (2008) 0.82
Increased QT interval variability in 3 recently concussed athletes: an exploratory observation. J Athl Train (2011) 0.82
Partial angiotensin-converting enzyme inhibition during acute orthostatic stress in persons with tetraplegia. J Spinal Cord Med (2005) 0.82
Common carotid and common femoral arterial dynamics during head-up tilt in persons with spinal cord injury. J Rehabil Res Dev (2004) 0.82
Difficulty with evacuation after spinal cord injury: colonic motility during sleep and effects of abdominal wall stimulation. J Rehabil Res Dev (2004) 0.81
QT/RR coherence is associated with testosterone levels in men with chronic spinal cord injury. Neuroendocrinology (2011) 0.81
Orthostatic effects of midodrine versus L-NAME on cerebral blood flow and the renin-angiotensin-aldosterone system in tetraplegia. Arch Phys Med Rehabil (2011) 0.81
Bacteriology of pressure ulcers in individuals with spinal cord injury: What we know and what we should know. J Spinal Cord Med (2014) 0.80
Development and psychometric characteristics of the SCI-QOL Bladder Management Difficulties and Bowel Management Difficulties item banks and short forms and the SCI-QOL Bladder Complications scale. J Spinal Cord Med (2015) 0.80
Anorectal stimulation causes increased colonic motor activity in subjects with spinal cord injury. J Spinal Cord Med (2007) 0.80
Spinal cord injury medicine. 4. Community reintegration after spinal cord injury. Arch Phys Med Rehabil (2007) 0.80
Androgens up-regulate transcription of the Notch inhibitor Numb in C2C12 myoblasts via Wnt/β-catenin signaling to T cell factor elements in the Numb promoter. J Biol Chem (2013) 0.80
A survey of protective cushion usage in individuals with spinal cord injury while traveling in a motor vehicle and on a commercial airliner. J Spinal Cord Med (2014) 0.80
Lean tissue mass and energy expenditure are retained in hypogonadal men with spinal cord injury after discontinuation of testosterone replacement therapy. J Spinal Cord Med (2014) 0.80
Nandrolone reduces activation of Notch signaling in denervated muscle associated with increased Numb expression. Biochem Biophys Res Commun (2011) 0.80
Effect of hypotensive challenge on systemic hemodynamics and cerebral blood flow in persons with tetraplegia. Clin Auton Res (2008) 0.80
Hemodynamic effects of L-threo-3,4-dihydroxyphenylserine (Droxidopa) in hypotensive individuals with spinal cord injury. Arch Phys Med Rehabil (2013) 0.80
Effects of neostigmine and glycopyrrolate on pulmonary resistance in spinal cord injury. J Rehabil Res Dev (2004) 0.79
Adaptation of computerized posturography to assess seated balance in persons with spinal cord injury. J Spinal Cord Med (2013) 0.79
Effects of nandrolone on denervation atrophy depend upon time after nerve transection. Muscle Nerve (2008) 0.79
Electrical stimulation modulates Wnt signaling and regulates genes for the motor endplate and calcium binding in muscle of rats with spinal cord transection. BMC Neurosci (2013) 0.78
Ankrd1 is a transcriptional repressor for the androgen receptor that is downregulated by testosterone. Biochem Biophys Res Commun (2013) 0.78
Orthostatic responses to nitric oxide synthase inhibition in persons with tetraplegia. Arch Phys Med Rehabil (2009) 0.78
Effects of acute nitric oxide synthase inhibition on lower leg vascular function in chronic tetraplegia. J Spinal Cord Med (2009) 0.78
An effective oral vitamin D replacement therapy in persons with spinal cord injury. J Spinal Cord Med (2011) 0.78
Spinal cord injury medicine. 3. Rehabilitation outcomes. Arch Phys Med Rehabil (2002) 0.78
A new assistive device for intermittent self-catheterization in men with tetraplegia. J Spinal Cord Med (2003) 0.78
Arm crank ergometry and shoulder pain in persons with spinal cord injury. Arch Phys Med Rehabil (2007) 0.78
Cold face test in persons with spinal cord injury: age versus inactivity. Clin Auton Res (2009) 0.78
Salmeterol improves pulmonary function in persons with tetraplegia. Lung (2006) 0.78